Skip to main content

Shefferman Jesse's Form 4 filing

Protara Therapeutics, Inc. (TARA) · filed Jul 1, 2026

Accession no.
0001213900-26-074238
Filed
Jul 1, 2026, 4:10 PM ET
Trade date
Jun 29-30, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 6 non-derivative transactions and 1 derivative transaction. Open-market sales total $882.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shefferman JesseCIK 0001799167Director, Officer (CEO and President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 29, 2026Common StockMOption exerciseAcquired+215,687$1.91+$411,962.17937,519Direct
Jun 29, 2026Common StockSSaleDisposed−215,687$4.09−$882,159.83721,832Direct
Jun 30, 2026Common StockGGiftDisposed−14,000$0.00$0707,832Direct
Jun 30, 2026Common StockGGiftDisposed−7,000$0.00$0700,832Direct
Jun 30, 2026Common StockGGiftDisposed−4,000$0.00$0696,832Direct
Jun 30, 2026Common StockGGiftDisposed−5,000$0.00$0691,832Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 29, 2026Common StockMOption exerciseDisposed−215,687$0.00$0141,313Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)